{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"89.300","rs_stock_flag":false,"fiscal_year_end":"2025年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"258,197,600","primaryexch":"香港交易所","ric":"1276.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BMV9P26","am":"431.04","iv":"","ew_strike":"","as":"87.300","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"87.250","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"52.500","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"孫飄揚","underlying_ric":"600276.SS","hi52":"92.300","issuer_name":"江蘇恒瑞醫藥股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"85.000","mkt_cap":"22.54","f_aum_hkd":null,"ew_sub_per_to":"","ls":"87.300","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-2.400","aum":"","issued_shares_class_B":null,"vo":"4.94","secondary_listing_flag":false,"listing_date":"2025年5月23日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"江蘇恒瑞醫藥股份有限公司 - H股","nm_s":"恒瑞醫藥","sym":"1276","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"江蘇恆瑞醫藥股份有限公司是一家主要從事藥品的研發、生產和銷售的中國公司。該公司專註於腫瘤領域，覆蓋激酶抑製劑、抗體偶聯藥物（ADC）、腫瘤免疫、激素受體調控、脫氧核糖核酸（DNA）修復及表觀遺傳、支持治療等研究領域。該公司的產品包括抗腫瘤、鎮痛麻醉和造影劑，應用於自身免疫疾病、代謝性疾病、心血管疾病、感染疾病、呼吸系統疾病、血液疾病、疼痛管理、神經系統疾病、眼科、腎病等領域。該公司主要在國內外市場開展其業務。","op":"86.900","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國江蘇省<br/>連雲港市<br/>經濟技術開發區<br/>黃河路38號","pc":"-2.68","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"89.700","isin":"CNE100006XS6","moneyness":""}},"qid":"1759074029630"}
